Yoon-Jae Cho

15.6k total citations · 2 hit papers
28 papers, 5.0k citations indexed

About

Yoon-Jae Cho is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yoon-Jae Cho has authored 28 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Yoon-Jae Cho's work include Hedgehog Signaling Pathway Studies (8 papers), Glioma Diagnosis and Treatment (6 papers) and Chromatin Remodeling and Cancer (6 papers). Yoon-Jae Cho is often cited by papers focused on Hedgehog Signaling Pathway Studies (8 papers), Glioma Diagnosis and Treatment (6 papers) and Chromatin Remodeling and Cancer (6 papers). Yoon-Jae Cho collaborates with scholars based in United States, Canada and Germany. Yoon-Jae Cho's co-authors include Scott L. Pomeroy, Marcel Kool, Stefan M. Pfister, Richard J. Gilbertson, Andrey Korshunov, Leonora Balaj, Lixin Dai, Xandra O. Breakefield, Johan Skog and Paul A. Northcott and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Yoon-Jae Cho

28 papers receiving 4.9k citations

Hit Papers

Molecular subgroups of medulloblastoma: the current conse... 2011 2026 2016 2021 2011 2011 400 800 1.2k

Peers

Yoon-Jae Cho
Marc Remke Germany
Rintaro Hashizume United States
S. Andrew United States
Brent A. Orr United States
Marc Remke Germany
Yoon-Jae Cho
Citations per year, relative to Yoon-Jae Cho Yoon-Jae Cho (= 1×) peers Marc Remke

Countries citing papers authored by Yoon-Jae Cho

Since Specialization
Citations

This map shows the geographic impact of Yoon-Jae Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon-Jae Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon-Jae Cho more than expected).

Fields of papers citing papers by Yoon-Jae Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon-Jae Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon-Jae Cho. The network helps show where Yoon-Jae Cho may publish in the future.

Co-authorship network of co-authors of Yoon-Jae Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon-Jae Cho. A scholar is included among the top collaborators of Yoon-Jae Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon-Jae Cho. Yoon-Jae Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nitta, Ryan T., et al.. (2019). Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene. 39(9). 2029–2029. 2 indexed citations
2.
Bolin, Sara, C. Persson, Anders Sundström, et al.. (2018). Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma. Oncogene. 37(21). 2850–2862. 62 indexed citations
3.
Yochum, Zachary A., Jessica Cades, Lucia Mazzacurati, et al.. (2017). A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer. Molecular Cancer Research. 15(12). 1764–1776. 69 indexed citations
4.
Seibel, Nita L., Katherine A. Janeway, Carl E. Allen, et al.. (2017). Pediatric oncology enters an era of precision medicine. Current Problems in Cancer. 41(3). 194–200. 34 indexed citations
5.
Phoenix, Timothy N., Deanna M. Patmore, Nidal Boulos, et al.. (2016). Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. Cancer Cell. 29(4). 508–522. 231 indexed citations
6.
Vitanza, Nicholas A. & Yoon-Jae Cho. (2015). Advances in the biology and treatment of pediatric central nervous system tumors. Current Opinion in Pediatrics. 28(1). 34–39. 5 indexed citations
7.
Zhang, Hongying, Jingbo Liu, Yoon-Jae Cho, et al.. (2014). EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. Journal of Neuro-Oncology. 121(1). 109–118. 11 indexed citations
8.
Burns, Timothy F., Irina Dobromilskaya, Sara C. Murphy, et al.. (2013). Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene-Driven Non–Small Cell Lung Cancer. Molecular Cancer Research. 11(4). 329–338. 51 indexed citations
9.
Dykhuizen, Emily C., Diana C. Hargreaves, Erik L. Miller, et al.. (2013). BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature. 497(7451). 624–627. 200 indexed citations
10.
Zhang, Hongying, Jingbo Liu, Joshua B. Rubin, et al.. (2013). Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration. Molecular Cancer. 12(1). 18–18. 34 indexed citations
11.
Northcott, Paul A., David Jones, Marcel Kool, et al.. (2012). Medulloblastomics: the end of the beginning. Nature reviews. Cancer. 12(12). 818–834. 449 indexed citations
12.
Pei, Yanxin, Colin E. Moore, Jun Wang, et al.. (2012). An Animal Model of MYC-Driven Medulloblastoma. Cancer Cell. 21(2). 155–167. 211 indexed citations
13.
Tran, Phuoc T., Emelyn H. Shroff, Timothy F. Burns, et al.. (2012). Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis. PLoS Genetics. 8(5). e1002650–e1002650. 80 indexed citations
14.
Weeraratne, Shyamal Dilhan, Vladimir Amani, Natalia Teider, et al.. (2012). Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathologica. 123(4). 539–552. 128 indexed citations
15.
Taylor, Michael D., Paul A. Northcott, Andrey Korshunov, et al.. (2011). Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathologica. 123(4). 465–472. 1241 indexed citations breakdown →
16.
Tamayo, Pablo, Yoon-Jae Cho, Aviad Tsherniak, et al.. (2011). Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Features. Journal of Clinical Oncology. 29(11). 1415–1423. 54 indexed citations
17.
Balaj, Leonora, Lixin Dai, Yoon-Jae Cho, et al.. (2011). Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nature Communications. 2(1). 180–180. 965 indexed citations breakdown →
18.
Teider, Natalia, Adrianne Neiss, Shyamal Dilhan Weeraratne, et al.. (2010). Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Neuro-Oncology. 12(12). 1244–1256. 30 indexed citations
19.
Wilson, Boris G., Xi Wang, Xiaohua Shen, et al.. (2010). Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation. Cancer Cell. 18(4). 316–328. 468 indexed citations
20.
Cho, Yoon-Jae, John J. Moskow, W. T. Schroeder, et al.. (1995). Epidermal Surface Antigen (M517S1) Is Highly Conserved between Mouse and Human. Genomics. 27(2). 251–258. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026